AMERISAFE (NASDAQ:AMSF – Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research note issued on Tuesday, Wall Street Zen reports.
Several other brokerages have also issued reports on AMSF. Morgan Stanley set a $40.00 target price on shares of AMERISAFE in a research note on Monday, October 12th. Weiss Ratings cut shares of AMERISAFE from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Tuesday, July 28th. Truist Financial dropped their price target on shares of AMERISAFE from $32.00 to $27.00 and set a “hold” rating for the company in a research note on Tuesday, October 13th. Zacks Research raised shares of AMERISAFE from a “strong sell” rating to a “hold” rating in a research note on Monday, September 28th. Finally, Citizens Jmp cut their price objective on shares of AMERISAFE from $42.00 to $40.00 and set a “market outperform” rating on the stock in a report on Monday, October 12th. Two equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $35.67.
View Our Latest Research Report on AMSF
AMERISAFE Stock Performance
Shares of AMSF opened at $25.52 on Tuesday. The business’s fifty day moving average price is $25.14 and its two-hundred day moving average price is $29.42. The firm has a market capitalization of $473.14 million, a price-to-earnings ratio of 12.68 and a beta of 0.24. AMERISAFE has a 52 week low of $23.20 and a 52 week high of $42.21.
AMERISAFE (NASDAQ:AMSF – Get Free Report) last announced its quarterly earnings data on Tuesday, July 21st. The insurance provider reported $0.44 EPS for the quarter, missing analysts’ consensus estimates of $0.52 by ($0.08). The firm had revenue of $91.97 million during the quarter, compared to analyst estimates of $85.09 million. AMERISAFE had a return on equity of 14.87% and a net margin of 14.00%. As a group, research analysts forecast that AMERISAFE will post 1.95 EPS for the current year.
Hedge Funds Weigh In On AMERISAFE
A number of large investors have recently added to or reduced their stakes in the company. Global Retirement Partners LLC bought a new stake in shares of AMERISAFE in the second quarter valued at about $26,000. Parallel Advisors LLC boosted its position in shares of AMERISAFE by 5,714.3% during the first quarter. Parallel Advisors LLC now owns 814 shares of the insurance provider’s stock worth $27,000 after buying an additional 800 shares during the period. Allworth Financial LP bought a new position in shares of AMERISAFE during the second quarter worth about $38,000. Versant Capital Management Inc grew its holdings in shares of AMERISAFE by 978.4% during the third quarter. Versant Capital Management Inc now owns 1,650 shares of the insurance provider’s stock worth $39,000 after buying an additional 1,497 shares in the last quarter. Finally, Quantbot Technologies LP acquired a new stake in AMERISAFE in the 2nd quarter valued at approximately $49,000. Institutional investors own 97.41% of the company’s stock.
AMERISAFE Company Profile
AMERISAFE, Inc (NASDAQ: AMSF) is a specialty workers’ compensation insurance company serving small and midsize employers in industries with elevated workplace risks. The company provides coverage designed to help businesses manage the costs associated with work-related injuries and occupational illnesses.
Its primary markets include construction, trucking, logging, agriculture, maritime operations, oil and gas, and other hazardous industries. In addition to insurance coverage, AMERISAFE emphasizes workplace safety, risk management, claims handling and return-to-work support to help policyholders reduce accidents and manage employee injuries.
Headquartered in DeRidder, Louisiana, AMERISAFE has historically focused on selected U.S.
Further Reading
- Five stocks we like better than AMERISAFE
- GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall?
- Intercepting Growth: Karman Secures $218M Lockheed Martin Deal
- Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs
- Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors
Receive News & Ratings for AMERISAFE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMERISAFE and related companies with MarketBeat.com's FREE daily email newsletter.
